Raquel Rodríguez-Pérez

Raquel Rodríguez-Pérez

Auto-generated profile, based on publicly available information

Raquel Rodríguez-Pérez

Novartis Biomedical Research, Novartis Campus, Basel 4002, Switzerland

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 May 2020 in Journal of Computer-Aided Molecular Design
Verified
Journal Article
Open access
PDF file
RRRaquel Rodríguez-Pérez
Raquel Rodríguez-Pérez
Jürgen BajorathJürgen Bajorath
Jürgen Bajorath
Difficulties in interpreting machine learning (ML) models and their predictions limit the practical applicability of and confidence in ML in pharmaceutical research. There is a need for agnostic approaches aiding in the interpretation of ML models regardless of their complexity that is also applicable to deep neural network (DNN) architectures and model ensembles. To these ends, the SHapley Additive exPlanations (SHAP) methodology has recently been introduced. The SHAP approach enables the identification and prioritization of features that determine compound classification and activity prediction using any ML model. Herein, we further extend the evaluation of the SHAP methodology by investigating a variant for exact calculation of Shapley values for decision tree methods and systematically compare this variant in compound activity and potency value predictions with the model-independent SHAP method. Moreover, new applications of the SHAP analysis approach are presented including interpretation of DNN models for the generation of multi-target activity profiles and ensemble regression models for potency prediction.


11 September 2025 in Journal of Chemical Information and Modeling
Verified
Journal Article
Closed access
JAJeremy R. Ash
Jeremy R. Ash
CWCas Wognum
Cas Wognum
RRRaquel Rodríguez-Pérez
Raquel Rodríguez-Pérez
MAMatteo Aldeghi
Matteo Aldeghi
ACAlan Cheng
Alan Cheng
WWW. Patrick Walters
W. Patrick Walters

4 October 2017 in ACS Omega
Verified
Journal Article
Open access
RRRaquel Rodríguez-Pérez
Raquel Rodríguez-Pérez
MVMartin Vogt
Martin Vogt
Jürgen BajorathJürgen Bajorath
Jürgen Bajorath
In computational chemistry and chemoinformatics, the support vector machine (SVM) algorithm is among the most widely used machine learning methods for the identification of new active compounds. In addition, support vector regression (SVR) has become a preferred approach for modeling nonlinear structure–activity relationships and predicting compound potency values. For the closely related SVM and SVR methods, fingerprints (i.e., bit string or feature set representations of chemical structure and properties) are generally preferred descriptors. Herein, we have compared SVM and SVR calculations for the same compound data sets to evaluate which features are responsible for predictions. On the basis of systematic feature weight analysis, rather surprising results were obtained. Fingerprint features were frequently identified that contributed differently to the corresponding SVM and SVR models. The overlap between feature sets determining the predictive performance of SVM and SVR was only very small. Furthermore, features were identified that had opposite effects on SVM and SVR predictions. Feature weight analysis in combination with feature mapping made it also possible to interpret individual predictions, thus balancing the black box character of SVM/SVR modeling.

29 June 2018 in Analytical and Bioanalytical Chemistry
Verified
Journal Article
Closed access
PDF file
RRRaquel Rodríguez-Pérez
Raquel Rodríguez-Pérez
LFLuis Fernández
Luis Fernández
Santiago MarcoSantiago Marco
Santiago Marco

9 July 2024 in Nature Communications
Verified
Journal Article
Open access
PDF file
GPGiulia Peteani
Giulia Peteani
MHMinh Tam Davide Huynh
Minh Tam Davide Huynh
GGGrégori Gerebtzoff
Grégori Gerebtzoff
RRRaquel Rodríguez-Pérez
Raquel Rodríguez-Pérez
Machine learning (ML) systems can model quantitative structure-property relationships (QSPR) using existing experimental data and make property predictions for new molecules. With the advent of modalities such as targeted protein degraders (TPD), the applicability of QSPR models is questioned and ML usage in TPD-centric projects remains limited. Herein, ML models are developed and evaluated for TPDs’ property predictions, including passive permeability, metabolic clearance, cytochrome P450 inhibition, plasma protein binding, and lipophilicity. Interestingly, performance on TPDs is comparable to that of other modalities. Predictions for glues and heterobifunctionals often yield lower and higher errors, respectively. For permeability, CYP3A4 inhibition, and human and rat microsomal clearance, misclassification errors into high and low risk categories are lower than 4% for glues and 15% for heterobifunctionals. For all modalities, misclassification errors range from 0.8% to 8.1%. Investigated transfer learning strategies improve predictions for heterobifunctionals. This is the first comprehensive evaluation of ML for the prediction of absorption, distribution, metabolism, and excretion (ADME) and physicochemical properties of TPD molecules, including heterobifunctional and molecular glue sub-modalities. Taken together, our investigations show that ML-based QSPR models are applicable to TPDs and support ML usage for TPDs’ design, to potentially accelerate drug discovery.